RENVELA® TABLETS


Film-coated tablets
scheduling status
S4
registration number
45/32.16/0305
What RENVELA® TABLETS contains
800 mg of sevelamer carbonate on an anhydrous basis.
other ingredients
Tablet core: Microcrystalline cellulose Sodium chloride Zinc stearate Film coating: Opadry Clear containing: Diacetylated monoglycerides Hypromellose (E464).
Therapeutic classification
V03A E02.
© 2026 SAHPRA. ALL RIGHTS RESERVED